Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

A Fart-tracking Kickstarter Wants You To Stop Cutting The Cheese

Votes for dead, penis vote: UK election's odd facts - Yahoo News

Image: I Want CH4 Flatus occurs mainly when we swallow small amounts of air while eating or drinking, and said food is then broken down into certain gases. This takes place in the digestive tract. You can blame methane and hydrogen sulfide for the less-than-pleasant odor. Bacteria overgrowth can also cause farting. And c'mon, everybody farts it's normal to pass gas between 13 and 21 times a day.
For the original version including any supplementary images or video, visit http://mashable.com/2015/05/09/fart-tracker-ch4/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial&utm_medium=feed&utm_source=rss

CH4 As of March31, 2015 the Company had $53 million in cash and investments, approximately $92 million in total assets, and no debt. Cumberland also had $44 million in tax net operating loss carryforwards, resulting from the prior exercise of stock options. QUARTER HIGHLIGHTS: Received FDA acceptance to review the Caldolor supplemental New Drug Application (sNDA) requesting a label update with pediatric information.
For the original version including any supplementary images or video, visit http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-reports-first-quarter-2015-financial-results-300079729.html

Cumberland Pharmaceuticals Reports First Quarter 2015 Financial Results -- NASHVILLE, Tenn., May 7, 2015 /PRNewswire/ --

PR Newswire "I wasn't remotely on the network's radar, but my reps at the time used the recent Seinfeld gig to open the eyes of the executives at CBS," he writes in twitter his memoir, which hit bookstores on May 5. Getty Originally, lead character Ray Barone's brother was supposed to be short and scrappy but Garrett auditioned at a towering 6' 8"! "I knew I could downplay my size by keeping Robbie succumbed in life's race with Foods That Cause Flatulence Ray," Garrett explains. He was hired almost immediately. "I met Raymond and promptly felt that we were doomed," he writes.
For the original version including any supplementary images or video, visit http://radaronline.com/photos/everybody-loves-raymond-secrets-brad-garrett-boob-jobs-boozy-nights-tell-all/photo/1047650/

?Everybody Loves Raymond? Secrets ? Brad Garrett Talks Boob Jobs, Boozy Nights With Sitcom Cast In New Tell-All | Radar Online

everybody-loves-raymond-secrets-001 -- Three Cabinet ministers lost their seats, all Liberal Democrats: Treasury chief secretary Danny Alexander, business secretary Vince Cable and energy secretary Ed Davey. -- For the sixth straight time, Houghton and Sunderland South in northeast England became the first constituency to declare a result, 48 minutes after the polls closed. -- The final declaration was England's most southwesterly constituency, St Ives, 17 hours and 30 minutes on.
For the original version including any supplementary images or video, visit http://news.yahoo.com/votes-dead-penis-vote-uk-elections-odd-facts-230910238.html

Progenics Pharmaceuticals Announces First Quarter 2015 Financial Results - Yahoo Finance

Scott T. Tagawa, M.D., both of Weill Cornell Medical College, initiated an investigator-sponsored Phase 2 study designed to evaluate 1404 in approximately 12 men with metastatic castration-resistant prostate cancer who plan to initiate androgen resistant-pathway targeted therapy. In February, the Company presented positive Phase 2 data for PSMA Excessive Gas Problems ADC in patients with metastatic castration-resistant prostate cancer at the American Society of Clinical Oncology Genitourinary Cancers Symposium, including new data from the recently completed chemo-naive cohort. Treatment with PSMA ADC reduced tumor size and levels of PSA and CTCs (circulating tumor cells), evidencing strong anti-tumor activity and a generally well tolerated safety profile with neutropenia the most common treatment related adverse event. In January, Progenics announced that the first patient had been dosed in the resumed pivotal Phase 2 study of Azedra(TM) in patients with malignant pheochromocytoma and paraganglioma, an ultra-orphan indication. Conference Call and Webcast Progenics will review first quarter financial results in a conference call today at 8:30 a.m. EDT.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/progenics-pharmaceuticals-announces-first-quarter-120000978.html

Don't be the product, buy the product!